Worldwide Clinical Trials appoints Evelyn Graham
To lead sales, marketing and business development for late-stage business
With more than 20 years of drug development experience, Graham will lead sales, marketing and business development strategies for the late stage business.
Graham was formerly chief executive of TorreyPines Therapeutics and led the company’s merger with Raptor Pharmaceuticals in September 2009.
You may also like
Research & Development
![Rethinking the route to first-in-human studies]()
Rethinking the route to first-in-human studies
For sponsors, development activities and fragmented clinical supply can slow the path from candidate selection to first-in-human (FIH) dosing. A more integrated approach can reduce avoidable complexity while preserving the flexibility needed for early clinical programmes
Research & Development
![Stablepharma doses first participant in Phase IIb trial of fridge-free tetanus-diphtheria vaccine]()
Stablepharma doses first participant in Phase IIb trial of fridge-free tetanus-diphtheria vaccine
The 160-person non-inferiority study is the final development step for the StablevaX-reformulated vaccine SPVX02, before commercialisation of a cold-chain-independent alternative to Tetadif
Manufacturing
![Making blister package integrity testing decisions that QA can use]()
Making blister package integrity testing decisions that QA can use
A blister package integrity testing strategy should give QA evidence that is relevant, repeatable, and practical to review. That means understanding the pack format, the likely leak risk, the sampling approach, and the records needed for routine decisions
